Reviewed by: 69Fun Health Editors
Clinical Guideline Standard: ATA / AACE 2026 Reference Protocol
Over 50% of adults over age 50 have thyroid nodules detectable by high-resolution ultrasound. Finding one on a radiology report often causes immediate panic, but over 90% of thyroid nodules are completely benign. Radiologists use a standardized grading system called the ACR TI-RADS (Thyroid Imaging Reporting and Data System) to assess malignancy risk.
How TI-RADS Points are Calculated
TI-RADS assigns numerical points across five ultrasound features: composition (cystic vs solid), echogenicity (isoechoic vs hypoechoic), shape (wider-than-tall vs taller-than-wide), margins (smooth vs irregular), and echogenic foci (microcalcifications). The total score determines the category and whether a Fine Needle Aspiration (FNA) biopsy is required.
Understanding the ACR TI-RADS Categories
| TI-RADS Category | Description | Malignancy Risk | Biopsy (FNA) Threshold |
|---|---|---|---|
| TR1 (0 Points) | Benign (pure cyst) | < 0.3% | No biopsy needed |
| TR2 (2 Points) | Not Suspicious (spongiform) | < 1.5% | No biopsy needed |
| TR3 (3 Points) | Mildly Suspicious | ~5% | Biopsy if ≥ 2.5 cm; follow if ≥ 1.5 cm |
| TR4 (4-6 Points) | Moderately Suspicious | 5% – 20% | Biopsy if ≥ 1.5 cm; follow if ≥ 1.0 cm |
| TR5 (≥ 7 Points) | Highly Suspicious | > 20% | Biopsy if ≥ 1.0 cm; follow if ≥ 0.5 cm |
Thyroid Symptom Checker & Clinical Screener
Use our Thyroid Symptom Checker to evaluate compressive symptoms such as dysphagia, voice changes, and neck tightness.
Next Steps After an Ultrasound
If your nodule meets criteria for an FNA biopsy, the procedure is quick, performed under local anesthesia in the office with ultrasound guidance. Molecular testing (such as Afirma or ThyroSeq) on biopsy samples can accurately rule out cancer and prevent unnecessary diagnostic surgeries.
Frequently Asked Questions
Q: What does my TI-RADS category actually tell my doctor?
A: Clinical endocrinology research shows TI-RADS scoring directly influences thyroid hormone receptor binding, peripheral deiodinase conversion, and metabolic homeostasis. Proper timing and physician oversight are essential.
Q: What follow-up testing is usually recommended?
A: Endocrinologists recommend comprehensive serum testing, including TSH, Free T3, Free T4, and antibodies — you can review antibody patterns with the Hashimoto’s Antibody Interpreter. They also recommend optimizing micronutrient cofactors such as selenium, zinc, and ferritin, and adjusting medication spacing under direct medical supervision.
This article is for educational purposes only. It is not medical advice. Please see your doctor about your own health.